Market Overview:
The global DVT screening and treatment devices market is expected to grow at a CAGR of 7.5% during the forecast period from 2018 to 2030. The market growth can be attributed to factors such as the increasing incidence of venous thromboembolism (VTE), technological advancements in screening and treatment devices, and rising demand for minimally invasive procedures. Based on type, the global DVT screening and treatment devices market is segmented into imaging modalities, intravascular ultrasound (IVUS), venous stenting, compression stockings, and others. The imaging modalities segment is further divided into ultrasonography, computed tomography (CT), magnetic resonance imaging (MRI), positron emission tomography/computed tomography (PET/CT) scanning, single-photon emission computed tomography (SPECT)/CT scanning; while the intravascular ultrasound segment is further classified into 2D IVUS systems and 3D IVUS systems. In terms of application, the global DVT screening and treatment devices market is categorized into hospitals & clinics and others segments.
Product Definition:
DVT Screening and Treatment Devices are used to prevent and treat deep vein thrombosis (DVT), a condition in which a blood clot forms in one of the deep veins in the body. DVT can cause pain, swelling, and redness in the affected area, as well as shortness of breath and other complications. The use of DVT Screening and Treatment Devices helps to prevent these problems by preventing clots from forming or breaking up existing clots.
Imaging Modalities:
Imaging modalities are the techniques used to create, view, and store images. The imaging modalities market is segmented into ultrasound systems, MRI systems CT scanners and X-ray machines. Imaging modality devices are widely used in various applications such as cardiology & cardiovascular disease diagnosis; oncology & cancer diagnosis; neurology & neurosurgery; musculoskeletal disorders including sports medicine and arthroscopy etc.
Intravascular Ultrasound:
Intravascular ultrasound (IVUS) is a diagnostic imaging technique used to evaluate the blood vessels. It creates an image of the inside of a vein using high-frequency sound waves and displays this image on a computer screen. The IVUS test helps in detecting blockage or lesions in the blood vessels which may cause problems if left unattended, for instance, deep vein thrombosis (DVT) or pulmonary embolism (PE).
Application Insights:
Based on application, the market is segmented into hospitals and clinics, other healthcare facilities and private practices. Hospitals and clinics held the largest share in 2017 owing to factors such as a high prevalence of patients suffering from deep vein thrombosis (DVT) that require treatment at primary healthcare facilities. Moreover, rising awareness among clinicians regarding DVT screening & treatment methods is further expected to drive the hospital segment over the forecast period. Other applications include military hospitals and private practices.
The others application segment includes travel medicine physicians who treat DVT during travels or while boarding an airplane if patient has symptoms of pulmonary embolism (PE). Increasing number of travelers¢â‚¬â„¢ exposure to various risk factors for developing PEs such as surgery or trauma associated with long-distance travels increases demand for early diagnosis which eventually drives this particular segment over the forecast period.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to the presence of key players, high adoption rate of advanced technologies, and favorable reimbursement policies. The U.S., which is at the forefront of this regional market, has a well-developed healthcare infrastructure and is one of the most lucrative markets for medical devices globally.
Growth Factors:
- Increasing incidence of deep vein thrombosis (DVT) and pulmonary embolism (PE)
- Growing awareness about DVT and its associated risks
- Rising demand for minimally invasive procedures for the treatment of DVT
- Technological advancements in screening and treatment devices for DVT
- increasing healthcare expenditure
Scope Of The Report
Report Attributes
Report Details
Report Title
DVT Screening and Treatment Devices Market Research Report
By Type
Imaging Modalities, Intravascular Ultrasound, Venous Stenting, Compression Stockings, Others
By Application
Hospitals and Clinics, Others
By Companies
F. Hoffmann-La Roche, Generex Biotechnology, Laboratorios Farmaceuticos Rovi, Pharmathen Pharmaceuticals, Bristol-Myers Squibb, 3SBio, Dupont, Wockhardt, Bayer, Pfizer
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
240
Number of Tables & Figures
168
Customization Available
Yes, the report can be customized as per your need.
Global DVT Screening and Treatment Devices Market Report Segments:
The global DVT Screening and Treatment Devices market is segmented on the basis of:
Types
Imaging Modalities, Intravascular Ultrasound, Venous Stenting, Compression Stockings, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals and Clinics, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- F. Hoffmann-La Roche
- Generex Biotechnology
- Laboratorios Farmaceuticos Rovi
- Pharmathen Pharmaceuticals
- Bristol-Myers Squibb
- 3SBio
- Dupont
- Wockhardt
- Bayer
- Pfizer
Highlights of The DVT Screening and Treatment Devices Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Imaging Modalities
- Intravascular Ultrasound
- Venous Stenting
- Compression Stockings
- Others
- By Application:
- Hospitals and Clinics
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the DVT Screening and Treatment Devices Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
DVT screening and treatment devices are medical devices that help identify individuals at risk for developing DVT. These devices can include a treadmill, an ultrasound machine, or a blood pressure cuff. The device will measure the person's heart rate and blood pressure while they are walking or standing. If either of these measurements increases significantly, it may indicate that the person is at risk for developing DVT.
Some of the major players in the dvt screening and treatment devices market are F. Hoffmann-La Roche, Generex Biotechnology, Laboratorios Farmaceuticos Rovi, Pharmathen Pharmaceuticals, Bristol-Myers Squibb, 3SBio, Dupont, Wockhardt, Bayer, Pfizer.
The dvt screening and treatment devices market is expected to grow at a compound annual growth rate of 7.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. DVT Screening and Treatment Devices Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. DVT Screening and Treatment Devices Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. DVT Screening and Treatment Devices Market - Supply Chain
4.5. Global DVT Screening and Treatment Devices Market Forecast
4.5.1. DVT Screening and Treatment Devices Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. DVT Screening and Treatment Devices Market Size (000 Units) and Y-o-Y Growth
4.5.3. DVT Screening and Treatment Devices Market Absolute $ Opportunity
5. Global DVT Screening and Treatment Devices Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. DVT Screening and Treatment Devices Market Size and Volume Forecast by Type
5.3.1. Imaging Modalities
5.3.2. Intravascular Ultrasound
5.3.3. Venous Stenting
5.3.4. Compression Stockings
5.3.5. Others
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global DVT Screening and Treatment Devices Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. DVT Screening and Treatment Devices Market Size and Volume Forecast by Application
6.3.1. Hospitals and Clinics
6.3.2. Others
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global DVT Screening and Treatment Devices Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. DVT Screening and Treatment Devices Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global DVT Screening and Treatment Devices Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. DVT Screening and Treatment Devices Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global DVT Screening and Treatment Devices Demand Share Forecast, 2019-2026
9. North America DVT Screening and Treatment Devices Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America DVT Screening and Treatment Devices Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America DVT Screening and Treatment Devices Market Size and Volume Forecast by Application
9.4.1. Hospitals and Clinics
9.4.2. Others
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America DVT Screening and Treatment Devices Market Size and Volume Forecast by Type
9.7.1. Imaging Modalities
9.7.2. Intravascular Ultrasound
9.7.3. Venous Stenting
9.7.4. Compression Stockings
9.7.5. Others
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America DVT Screening and Treatment Devices Demand Share Forecast, 2019-2026
10. Latin America DVT Screening and Treatment Devices Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America DVT Screening and Treatment Devices Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America DVT Screening and Treatment Devices Market Size and Volume Forecast by Application
10.4.1. Hospitals and Clinics
10.4.2. Others
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America DVT Screening and Treatment Devices Market Size and Volume Forecast by Type
10.7.1. Imaging Modalities
10.7.2. Intravascular Ultrasound
10.7.3. Venous Stenting
10.7.4. Compression Stockings
10.7.5. Others
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America DVT Screening and Treatment Devices Demand Share Forecast, 2019-2026
11. Europe DVT Screening and Treatment Devices Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe DVT Screening and Treatment Devices Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe DVT Screening and Treatment Devices Market Size and Volume Forecast by Application
11.4.1. Hospitals and Clinics
11.4.2. Others
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe DVT Screening and Treatment Devices Market Size and Volume Forecast by Type
11.7.1. Imaging Modalities
11.7.2. Intravascular Ultrasound
117.3. Venous Stenting
11.7.4. Compression Stockings
11.7.5. Others
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe DVT Screening and Treatment Devices Demand Share, 2019-2026
12. Asia Pacific DVT Screening and Treatment Devices Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific DVT Screening and Treatment Devices Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific DVT Screening and Treatment Devices Market Size and Volume Forecast by Application
12.4.1. Hospitals and Clinics
12.4.2. Others
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific DVT Screening and Treatment Devices Market Size and Volume Forecast by Type
12.7.1. Imaging Modalities
12.7.2. Intravascular Ultrasound
12.7.3. Venous Stenting
12.7.4. Compression Stockings
12.7.5. Others
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific DVT Screening and Treatment Devices Demand Share, 2019-2026
13. Middle East & Africa DVT Screening and Treatment Devices Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa DVT Screening and Treatment Devices Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa DVT Screening and Treatment Devices Market Size and Volume Forecast by Application
13.4.1. Hospitals and Clinics
13.4.2. Others
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa DVT Screening and Treatment Devices Market Size and Volume Forecast by Type
13.7.1. Imaging Modalities
13.7.2. Intravascular Ultrasound
13.7.3. Venous Stenting
13.7.4. Compression Stockings
13.7.5. Others
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa DVT Screening and Treatment Devices Demand Share, 2019-2026
14. Competition Landscape
14.1. Global DVT Screening and Treatment Devices Market: Market Share Analysis
14.2. DVT Screening and Treatment Devices Distributors and Customers
14.3. DVT Screening and Treatment Devices Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. F. Hoffmann-La Roche
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Generex Biotechnology
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Laboratorios Farmaceuticos Rovi
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Pharmathen Pharmaceuticals
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Bristol-Myers Squibb
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. 3SBio
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Dupont
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Wockhardt
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Bayer
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Pfizer
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook